PMEF
PRLD icon

Point72 Middle East FZE’s Prelude Therapeutics PRLD Stock Holding History

Point72 Middle East FZE’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,680
Closed -$9.58K – 1428
2023
Q1 		$9.58K Buy
+1,680
New +$9.58K ﹤0.01% 939